Honokiol
규격
35354-74-6CAS 번호
609-119-8EC 번호
2-(4-hydroxy-3-prop-2-enylphenyl)-4-prop-2-enylphenolIUPAC 명칭
C18H18O2화학식
266.3 g/mol분자량
Honokiol; 35354-74-6; 3,5'-Diallyl-4,2'-dihydroxybiphenyl; Purinol; 4-allyl-2-(3-allyl-4-hydroxy-phenyl)phenol; 2-(4-hydroxy-3-prop-2-enylphenyl)-4-prop-2-enylphenol; DTXSID30188845; 11513CCO0N; FMLT BSASM H; NSC-293100; (1,1'-BIPHENYL)-2,4'-DIOL, 3',5-DI-2-PROPEN-1-YL-; RefChem:788486; DTXCID90111336; 609-119-8; 5,3'-Diallyl-2,4'-dihydroxybiphenyl; NSC 293100; 3',5-Di-2-propen-1-yl[1,1'-biphenyl]-2,4'-diol; 3',5-diallyl-2,4'-biphenyldiol; MFCD00016674; 3',5-diallyl-[1,1'-biphenyl]-2,4'-diol; 3',5-Diallylbiphenyl-2,4'-diol; CPD000387107; CHEMBL16901; NSC293100; s2310; [1,1'-Biphenyl]-2,4'-diol, 3',5-di-2-propenyl-; (1P)-3',5-di(prop-2-en-1-yl)[1,1'-biphenyl]-2,4'-diol; 2-[4-hydroxy-3-(prop-2-en-1-yl)phenyl]-4-(prop-2-en-1-yl)phenol; SMR000387107; (1,1'-BIPHENYL)-2,4'-DIOL, 3',5-DI-2-PROPENYL-; UNII-11513CCO0N; Honokiol?; -dihydroxydiphenyl; Honokiol CRS; Honokiol, HO; 3',5-Di-2-propen-1-yl-[1,1'-biphenyl]-2,4'-diol; [1,1'-Biphenyl]-2,4'-diol, 3',5-di-2-propenyl- (9CI); 3',5-Diallyl-2,4'-biphenyldiol; Honokiol; NSC 293100; Y4T; Honokiol (Standard); 5,3′ Honokiol - 98%; -Diallyl-2,4′ HONOKIOL [MI]; HONOKIOL [WHO-DD]; Honokiol, analytical standard; cid_72303; MLS000759481; MLS001048916; MLS001423980; MLS006011755; SCHEMBL133034; REGID_for_CID_72303; CHEBI:5759; orb1304634; orb3139948; SCHEMBL29363985; SCHEMBL29384099; SCHEMBL30008303; GTPL11610; HY-N0003R; MSK1624; 3',1'-biphenyl)-2,4'-diol; 2-(4-hydroxy-3-prop-2-enyl-phenyl)- 4-prop-2-enyl-phenol; GLXC-06954; HMS2051C12; HMS2271J07; HMS3393C12; HMS3656G03; HMS5080L08; HY-N0003; 5,3'-Diallyl-biphenyl-2,4'-diol; AC-486; BDBM50157304; EBC-11157; HB0328; STK801954; 3'',5-diallylbiphenyl-2,4''-diol; Honokiol, >=98% (HPLC), powder; 3,5'-diallyl-2',4-dihydroxybiphenyl; AKOS005622639; Honokiol - 98% - Bio-X trade mark; 3',5-Diallyl-2,4'-dihydroxybiphenyl; CCG-100864; CS-1696; FH09766; NC00114; 5,3''-Diallyl-biphenyl-2,4''-diol; SMP2_000040; 3',3'-Diallyl-4,6'-dihydroxybiphenyl; NCGC00163567-01; NCGC00163567-02; NCGC00163567-03; NCGC00163567-08; AS-15333; BH300084; 5,3''''-Diallyl-biphenyl-2,4''''-diol; H1309; H5654; NS00011726; SW197494-3; 3',5-di(prop-2-en-1-yl)biphenyl-2,4'-diol; EN300-7399522; 3',5-di-2-propenyl-1,1'-biphenyl-2,4'-diol; F221573; SR-01000758208; Q5896650; SR-01000758208-5; {1,1'-Biphenyl]-2,4'-diol, 3,5-di-2-propenyl-; 3'',5-di-2-propenyl-1,1''-biphenyl-2,4''-diol; BRD-K98493452-001-01-6; BRD-K98493452-001-14-9; Honokiol, European Pharmacopoeia (EP) Reference Standard; Z2065671480; [1,1'-Biphenyl]-2,4'-diol, 3',5-di-2-propen-1-yl; 2-(4-hydroxy-3-prop-2-enyl-phenyl)-4-prop-2-enyl-phenol; 3',5-Di(prop-2-en-1-yl)[1,1'-biphenyl]-2,4'-diol; 4-[2-hydroxy-5-(prop-2-en-1-yl)phenyl]-2-(prop-2-en-1-yl)phenol; 3',5-Diallyl-[1,1'-biphenyl]-2,4'-diol compound with 5,5'-diallyl-[1,1'-biphenyl]-2,2'-diol; InChI=1/C18H18O2/c1-3-5-13-7-9-18(20)16(11-13)14-8-10-17(19)15(12-14)6-4-2/h3-4,7-12,19-20H,1-2,5-6H; N-[[4-([1,2,4]Triazolo[1,5-a]pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1H-imidazol-2-yl]methyl]-2-fluoroaniline; N-?(2-?Fluorophenyl)?-?5-?(6-?methyl-?2-?pyridinyl)?-?4-?[1,?2,?4]?triazolo[1,?5-?a]?pyridin-?6-?yl-1H-?imidazole-?2-?methanamine동의어